Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice

OBJECTIVE: To formulate a decision analysis model based on recently published data that addresses the dilemma, whether improvement in quality of life rationalises continued proton pump inhibitors (PPI) use despite the risk of gastric cancer (GC) in patients with functional dyspepsia (FD). DESIGN: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Broide, Efrat, Eindor-Abarbanel, Adi, Shirin, Haim, Richter, Vered, Matalon, Shay, Leshno, Moshe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045183/
https://www.ncbi.nlm.nih.gov/pubmed/32051298
http://dx.doi.org/10.1136/bmjopen-2019-031091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045183/
https://www.ncbi.nlm.nih.gov/pubmed/32051298
http://dx.doi.org/10.1136/bmjopen-2019-031091

Ejemplares similares